"Dr. Marshall Schreeder has practiced medicine in Huntsville since 1979. Dr. Schreeder is board certified in both Internal Medicine and Medical Oncology."

During the past decade, Marshall Schreeder, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Marshall Schreeder, MD" are "Carcinoma, Non-Small Cell Lung" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Lung Cancer" (1 trials), "Neoplasms, Lung" (1 trials) and "Neoplasms, Pulmonary" (1 trials). Many other conditions were trialed in "Marshall Schreeder, MD" in a lesser frequency.

Most popular intervention types in "Marshall Schreeder, MD" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (1 trials), "pemetrexed" (1 trials), "talabostat" (1 trials) and "talabostat mesylate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marshall Schreeder, MD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Marshall Schreeder, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Marshall Schreeder, MD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Marshall Schreeder, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".